Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Change in Cash (2016 - 2025)

Historic Change in Cash for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $115.3 million.

  • Pediatrix Medical's Change in Cash rose 3659.64% to $115.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $236.2 million, marking a year-over-year increase of 18581.04%. This contributed to the annual value of $156.7 million for FY2024, which is 14700.0% up from last year.
  • Latest data reveals that Pediatrix Medical reported Change in Cash of $115.3 million as of Q3 2025, which was up 3659.64% from $125.8 million recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's Change in Cash registered a high of $126.1 million during Q4 2024, and its lowest value of -$854.2 million during Q1 2021.
  • Its 5-year average for Change in Cash is -$41.3 million, with a median of $11.4 million in 2024.
  • As far as peak fluctuations go, Pediatrix Medical's Change in Cash surged by 440510.38% in 2023, and later tumbled by 166378.38% in 2024.
  • Quarter analysis of 5 years shows Pediatrix Medical's Change in Cash stood at $29.5 million in 2021, then plummeted by 96.08% to $1.2 million in 2022, then skyrocketed by 4405.1% to $52.1 million in 2023, then surged by 142.15% to $126.1 million in 2024, then fell by 8.55% to $115.3 million in 2025.
  • Its last three reported values are $115.3 million in Q3 2025, $125.8 million for Q2 2025, and -$131.0 million during Q1 2025.